Madigral ( MDGL) appears to be the NASH frontrunner and first serious threat to see an FDA approval. Link below to press release on one of the recent readouts from PH III trials. Science guys on the board can compare/contrast with CYDY.

https://ir.madrigalpharma.com/node/13851/pdf